Cargando…

Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies

Since researchers identified α-synuclein as the principal component of Lewy bodies and Lewy neurites, studies have suggested that it plays a causative role in the pathogenesis of dementia with Lewy bodies and other ‘synucleinopathies’. While α-synuclein dyshomeostasis likely contributes to the neuro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanderson, John B, De, Suman, Jiang, Haiyang, Rovere, Matteo, Jin, Ming, Zaccagnini, Ludovica, Hays Watson, Aurelia, De Boni, Laura, Lagomarsino, Valentina N, Young-Pearse, Tracy L, Liu, Xinyue, Pochapsky, Thomas C, Hyman, Bradley T, Dickson, Dennis W, Klenerman, David, Selkoe, Dennis J, Bartels, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130446/ https://www.ncbi.nlm.nih.gov/pubmed/32280944 http://dx.doi.org/10.1093/braincomms/fcaa010

Ejemplares similares

Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations
por: de Boni, Laura, et al.
Publicado: (2022)

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
por: Bartels, Tim, et al.
Publicado: (2011)

Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s disease
por: Fonseca-Ornelas, Luis, et al.
Publicado: (2021)

N-Alpha-Acetylation of α-Synuclein Increases Its Helical Folding Propensity, GM1 Binding Specificity and Resistance to Aggregation
por: Bartels, Tim, et al.
Publicado: (2014)

Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity
por: Luth, Eric S., et al.
Publicado: (2014)

A New Method for Quantitative Immunoblotting of Endogenous α-Synuclein
por: Newman, Andrew J., et al.
Publicado: (2013)

Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
por: Dettmer, Ulf, et al.
Publicado: (2015)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

Corrigendum: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
por: Dettmer, Ulf, et al.
Publicado: (2015)

Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity
por: Ramalingam, Nagendran, et al.
Publicado: (2023)

Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase
por: Imberdis, Thibaut, et al.
Publicado: (2019)

Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking
por: Román-Vendrell, Cristina, et al.
Publicado: (2021)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Nanoparticles With Affinity for α-Synuclein Sequester α-Synuclein to Form Toxic Aggregates in Neurons With Endolysosomal Impairment
por: Jiang, Peizhou, et al.
Publicado: (2021)

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology
por: Jin, Yunjung, et al.
Publicado: (2022)

Human acireductone dioxygenase (HsARD), cancer and human health: Black hat, white hat or gray?
por: Liu, Xinyue, et al.
Publicado: (2019)

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
por: Stuendl, Anne, et al.
Publicado: (2016)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models
por: Lim, Melina J., et al.
Publicado: (2023)

α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
por: Schaser, Allison J., et al.
Publicado: (2020)

Structures of α-synuclein filaments from human brains with Lewy pathology
por: Yang, Yang, et al.
Publicado: (2022)

Distinct biological activity of Lewy body α-Synuclein strain in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
por: Kim, Tae-Eun, et al.
Publicado: (2021)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
por: Fujita, Masayo, et al.
Publicado: (2012)

Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
por: Chiasserini, Davide, et al.
Publicado: (2015)

Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
por: Fonseca-Ornelas, Luis, et al.
Publicado: (2022)

Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1
por: Young-Pearse, Tracy L, et al.
Publicado: (2008)

A cellular complex of BACE1 and γ-secretase sequentially generates Aβ from its full-length precursor
por: Liu, Lei, et al.
Publicado: (2019)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
por: Morris, Meaghan, et al.
Publicado: (2015)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

A toxic subset of soluble α-synuclein species in dementia with Lewy body
por: Castillo-Carranza, Diana L
Publicado: (2020)

Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
por: Leitão, André D. G., et al.
Publicado: (2021)

α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
por: Simon, Christopher, et al.
Publicado: (2021)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
por: Manzanza, Nelson de Oliveira, et al.
Publicado: (2021)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022)

E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity
por: Rovere, Matteo, et al.
Publicado: (2019)

Optical Structural Analysis of Individual α‐Synuclein Oligomers
por: Varela, Juan A., et al.
Publicado: (2018)

Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1
por: Miners, J Scott, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0dek6elf65lvdcgmqhr6cgds7o